Genpact (G) has gained new attention after partnering with Nestlé Business Solutions to build a global capability center in India, leveraging agent AI and process expertise to support Nestlé’s global operations.
Check out our latest analysis for Genpact.
Despite the new partnership with Nestlé and the recently announced quarterly dividend of $0.1875 per share, Genpact’s one-year total shareholder return decreased by 30.66% and year-to-date price return decreased by 32.72%. However, the recent 7-day stock price return of 5.18% suggests short-term momentum after a 90-day period where the stock dropped 16.36%.
If you’re interested in Genpact’s AI work with large customers, it might be helpful to widen your lens and look at other AI-focused businesses, starting with 62 AI stocks that aren’t just burning cash but are also profitable.
After a sharp drop in share price and recent rally, Genpact is now at a level where some investors may want to intervene, while others may wait for an even cheaper entry. How do current valuations stack up?
Most popular story: 27.2% are underrated
Genpact’s most followed article has a fair value of $42.45 per share, compared to the previous closing price of $30.89. This clearly spotlights the upside potential based on that framework.
Genpact’s strong pipeline, particularly in high-growth sectors such as high-tech, manufacturing and financial services, coupled with increased large-scale deal activity and stable operating leverage, is said to support above-sector average earnings and EPS growth, supported by expanding operating margins and continued return of capital to shareholders.
Read the whole story.
Want to understand why this story supports a higher value for Genpact? The core assumptions hinge on steady revenue growth, stronger profit margins, and a different future earnings multiple than the current stock price. It’s all about how these factors fit together, not just the headline fair value.
Result: Fair value $42.45 (undervalued)
Read the full explanation to understand what’s behind the predictions.
But Genpact’s story could go off track if its core outsourcing revenue slows sooner than expected or if larger AI-driven deals take longer to materialize.
Find out about the key risks to this Genpact story.
next step
If the mixed signals regarding Genpact make you inconvenient, now is a good time to act now and check the underlying metrics for yourself. To understand what investors find attractive in your current setup, start by looking at four key perks.
Looking for investment ideas other than Genpact?
If Genpact has sharpened your focus on quality opportunities, don’t stop here. A powerful idea to act on next might be to sit on a screener.
This article by Simply Wall St is general in nature. We provide commentary using only unbiased methodologies, based on historical data and analyst forecasts, and articles are not intended to be financial advice. This is not a recommendation to buy or sell any stock, and does not take into account your objectives or financial situation. We aim to provide long-term, focused analysis based on fundamental data. Note that our analysis may not factor in the latest announcements or qualitative material from price-sensitive companies. Simply Wall St has no position in any stocks mentioned.
new: Manage all your stock portfolios in one place
What we created is The ultimate portfolio companion For stock investors, And it’s free.
• Connect an unlimited number of portfolios and see the total in one currency
• Alert you to new warning signs and risks via email or mobile phone
• Track the fair value of stocks
Try our demo portfolio for free
Do you have feedback on this article? Interested in its content? Please contact us directly. Alternatively, email editorial-team@simplywallst.com.
